Scott A. Waldman
42Patents
14h-index
15Co-inventors
78Inventor score
Filing activity: Oct 26, 1993 → Dec 28, 2018
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US5518888A | ST receptor binding compounds and methods of using the same | Human Necessities | 109 | Expired |
| US6767704B2 | Methods of screening and diagnosing esophageal cancer by determining guanylin cyclase C expression | Physics | 101 | Expired |
| US7479376B2 | Compositions and methods for identifying and targeting cancer cells of alimentary canal origin | Physics | 80 | Expired |
| US5601990A | Methods of diagnosing colorectal tumors and metastasis thereof | Emerging Cross-Sectional Technologies | 78 | Expired |
| US5731159A | Methods of and kits and compositions for diagnosing colorectal tumors and metastasis thereof | Emerging Cross-Sectional Technologies | 67 | Expired |
| US5879656A | Methods of treating metastatic colorectal cancer with ST receptor binding compounds | Emerging Cross-Sectional Technologies | 67 | Expired |
| US6060037A | Compositions that specifically bind to colorectal cancer cells and methods of using the same | Physics | 65 | Expired |
| US6187536A | Methods of identifying and detecting pancreatic cancer | Chemistry; Metallurgy | 49 | Expired |
| US5928873A | Methods of and kits and compositions for diagnosing colorectal tumors and metastasis thereof | Emerging Cross-Sectional Technologies | 44 | Expired |
| US5962220A | Compositions that specifically bind to colorectal cells and methods of using the same | Chemistry; Metallurgy | 23 | Expired |
| US6120995A | Compositions that specifically bind to colorectal cancer cells and methods of using the same | Emerging Cross-Sectional Technologies | 21 | Expired |
| US6602659B1 | Methods of and kits and compositions for diagnosing colorectal tumors and metastasis thereof | Emerging Cross-Sectional Technologies | 20 | Expired |
| US9156915B2 | Anti-GCC antibody molecules | Physics | 20 | Active |
| US9393268B2 | Cell-based anti-cancer compositions with reduced toxicity and methods of making and using the same | Chemistry; Metallurgy | 17 | Active |
| US6455251B1 | Methods of and kits and compositions for diagnosing colorectal tumors and metastasis thereof | Emerging Cross-Sectional Technologies | 13 | Expired |
| US6942985B2 | Methods of and kits and compositions for diagnosing colorectal tumors and metastasis thereof | Emerging Cross-Sectional Technologies | 12 | Expired |
| US9662405B2 | Method of treating cancer by administering chimeric antigen receptor comprising anti-GCC antibody | Physics | 10 | Active |
| US7135333B1 | Compositions that specifically bind to colorectal cancer cells and methods of using the same | Chemistry; Metallurgy | 9 | Expired |
| US6268159A | Imaging of colorectal cancer using ST receptor binding compounds | Emerging Cross-Sectional Technologies | 9 | Expired |
| US6844153B2 | Compositions and methods for identifying and targeting cancer cells of alimentary canal origin | Physics | 9 | Expired |
| US7097839B1 | ST receptor binding compounds and methods of using the same | Emerging Cross-Sectional Technologies | 8 | Expired |
| US8206704B2 | Use of GCC ligands | Human Necessities | 6 | Active |
| US6087109A | Compositions that specifically bind to colorectal cancer cells and methods of using the same | Chemistry; Metallurgy | 5 | Expired |
| US7854933B2 | Compositions and methods for identifying and targeting cancer cells of alimentary canal origin | Physics | 5 | Active |
| US7785817B2 | Compositions and methods for identifying and targeting cancer cells of alimentary canal origin | Physics | 4 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.